The analyser features a large colour touchscreen and a user-friendly interface. Credit: Anbio Biotechnology/PRNewswire.

Anbio has introduced the Anbio AF-100S fluorescent immunoassay (FIA) solution to assist healthcare professionals in providing better care for their patients.

The handheld point-of-care immunodiagnostic solution provides quick and precise results for various analytes, including enzymes, infectious diseases and hormones.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Its easy-to-use interface enables its usage in various settings while high specificity and sensitivity ensure that patients receive accurate results.

A compact FIA analyser makes it suitable for use in ambulances, emergency rooms, urgent care facilities, as well as private clinics.

It can also process up to 240 tests per hour, thereby making it ideal for high-volume settings.

See Also:

A lithium battery that powers the analyser can provide up to 800 tests per charge or 20 days of device-off time.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In addition, the analyser features a large colour touchscreen and a user-friendly interface for easy operation.

The AF-100S FIA solution can detect the presence of specific biomolecules in the sample of a patient using fluorescently labelled antigens or antibodies.

If present, the biomolecule binds to the labelled molecules, forming a complex that releases a fluorescent signal.

This signal will be measured and compared to a standard for determining the concentration of the biomolecule in the patient sample.

Anbio chief marketing officer Sa Jiang said: “The Anbio AF-100S is set to transform the field of clinical diagnostics, empowering healthcare providers with a cost-effective and comprehensive solution.”